DiabCare Asia 2012: diabetes management, control, and complications in patients with type 2 diabetes in Indonesia

被引:21
作者
Cholil, Achmad Rudijanto [1 ]
Lindarto, Dharma [2 ]
Pemayun, Tjokorda Gde Dalem [3 ]
Wisnu, Wismandari [4 ]
Kumala, Poppy [5 ]
Puteri, Happy Helene Sulung [5 ]
机构
[1] Univ Brawijaya, Saiful Anwar Hosp, Fac Med, Dept Internal Med, Jalan Jaksa Agung Suprapto 1, Malang 65111, East Java, Indonesia
[2] Univ Sumatera Utara, Adam Malik Hosp, Fac Med, Dept Internal Med, Medan, Indonesia
[3] Univ Diponegoro, Kariadi Hosp, Fac Med, Dept Internal Med, Semarang, Indonesia
[4] Univ Indonesia, Cipto Mangunkusumo Hosp, Fac Med, Dept Internal Med, Jakarta, Indonesia
[5] Novo Nordisk Indonesia, Jakarta, Indonesia
关键词
diabcare; diabetes complication; diabetes mellitus; hypoglycemia; prevention; treatment adherence; RISK-FACTORS; OUTCOMES;
D O I
10.13181/mji.v28i1.2931
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Indonesia was a part of the most recent edition of DiabCare Asia held in 2008. DiabCare Asia 2012 is modeled after a similar project to provide the latest information to facilitate healthcare policymaking in this area. METHODS This was an observational, non-interventional, cross-sectional study of patients with type 2 diabetes mellitus from primary, secondary, and tertiary care centers in Indonesia. Patient data collected included demography, medical history complications, eye and foot examinations, diabetes management, and most recent laboratory investigations. Blood samples were collected from all patients for the analysis of glycated hemoglobin (HbA1c). RESULTS A total of 1,967 patients participated in the study, with a mean (SD) age of 58.4 (9.5) years and a median (range) duration of diabetes 6.0 (0.1-47.0) years. The percentage of patients with HbA1c <7.0% was 30.8% and the mean (SD) HbA1c level was 8.3 (2.2%). The proportion of patients using insulin was 34.7% with a mean (SD) total daily dose of 37.9 (24.1) IU. The most common diabetes-related complications were peripheral neuropathy (59.1%), erectile dysfunction (32.4%), and eye complications (29.1%). CONCLUSIONS Glycemic and metabolic control remain unsatisfactory in type 2 diabetes patients in Indonesia. Efforts are needed to optimize control and prevent complications in these patients.
引用
收藏
页码:47 / 56
页数:10
相关论文
共 27 条
  • [1] Standards of Medical Care in Diabetes-2014
    不详
    [J]. DIABETES CARE, 2014, 37 : S14 - S80
  • [2] [Anonymous], 2020, OPERATIONAL PLAN EHU
  • [3] [Anonymous], 2011, IDF diabetes atlas
  • [4] Diabetes in Asia Epidemiology, Risk Factors, and Pathophysiology
    Chan, Juliana C. N.
    Malik, Vasanti
    Jia, Weiping
    Kadowaki, Takashi
    Yajnik, Chittaranjan S.
    Yoon, Kun-Ho
    Hu, Frank B.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (20): : 2129 - 2140
  • [5] Chetthakul Thanya, 2006, Journal of the Medical Association of Thailand, V89, P56
  • [6] Comparisons of the outcomes on control, type of management and complications status in early onset and late onset type 2 diabetes in Asia
    Chuang, LM
    Soegondo, S
    Soewondo, P
    Kim, YS
    Mohamed, M
    Dalisay, E
    Go, R
    Lee, W
    Tai, TY
    Tandhanand, S
    Nitiyanant, W
    Mai, TT
    Cockram, C
    Yeo, JP
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 71 (02) : 146 - 155
  • [7] The status of diabetes control in Asia - a cross-sectional survey of 24 317 patients with diabetes mellitus in 1998
    Chuang, LM
    Tsai, ST
    Huang, BY
    Tai, TY
    [J]. DIABETIC MEDICINE, 2002, 19 (12) : 978 - 985
  • [8] Guidelines for good pharmacoepidemiology practices (GPP)
    Epstein, Mark
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (02) : 200 - 208
  • [9] International Diabetes Federation, 2017, IDF Diabetes Atlas, V8th ed.
  • [10] International Diabetes Federation, 2021, IDF Diabetes Atlas, V10th edition